Thymosin.net

The thymosins are a family of biologically active peptides with hormone-like properties that were first isolated in 1966.  Since that time, significant progress has been made in our understanding of the role of these molecules in immunity and the nature of the physiological processes they regulate.  Several of these small peptides, such as thymosin alpha 1 and thymosin beta 4, have been synthesized and shown to have important clinical applications.  The physiological processes that these peptides affect include stimulation or suppression of immune responses, regulation of actin dynamics and cell motility, neuroplasticity, repair and remodeling of vessels of the heart and other injured tissues, angiogenesis, and stem cell differentiation.  Several of these molecules have also been shown to be useful as molecular markers and as potential diagnostics in areas ranging from cancer and infectious diseases to autoimmune diseases and aging.

Thymosin is also called thymopeptide. It is a kind of polypeptide. It can affect the function of T cells in immune system and have anti-aging and tumor-resisting functions. Since the 1980s, the drugs of thymosin had already come on the market. And for the past 10 years, thymosin extracts have been able to be massed produced in Taiwan. In the last year the immune boosting affects of thymosin have reached English speaking markets.  Thymosin is currently being used in Asia to treat the following:

Cancer-resisting. Patients who suffer from cancers have defects in immune system. Chemotherapy and radiation therapy will worsen such defects. This forms the pathological basis of the application of thymosin. Thymosin can be used as immune modulator and mainly used to treat lung cancer. It is reported that applying thymosin in the chemotherapy of small-celled cancer (can not be excised through operations) can prolong patients life up to 65%. (There are 18 cases in the experimental group, wherein the average survival days is 434; 16 cases in the control group, wherein the average survival days is 263).

Treatment of autoimmune diseases. Some scientists use thymosin to treat lupus erythematosus. There are 49 cases, wherein the cure rate is up to 96.6%. The clinical syndromes can be improved and controlled. There are other reports showing that the cure rate of autoimmune diseases can be up to 72.9% after applying thymosin.

Enhance immune function of cells. An experiment was conducted to 59 old men who suffer from malfunction of immune system. After treating them with thymosin and vitamin E, their health conditions are improved. The syndrome of nocturia and the frequency of catching cold are decreased. Even when the patient catches a cold, he just suffers minor syndromes.

Infection-resisting. Thymosin has significant effect on infectious diseases. An experiment was conducted to 12 patients who suffer from severe infectious diseases. After treating them with thymosin, 8 patients are cured completely and 4 patients have significant improvement. According to the foreign research reports, preparations of calf thymosin have significant effect on patients who suffer from recurrent herpes labialis. There are 18 patients in the experiment, wherein 17 patients are cured completely. The preparations of calf thymosin show no effect only to 1 patient.

Treatment of AIDS. Some pilot experiments display that applying thymosin in the treatment of AIDS can enhance the reaction of patient’s lymphocytes, stimulate the formation of interleukin and escalate the standard of antibodies.  Experts have begun to pay attention to the application of thymosin in such treatment.  

This community based site is designed to bring awareness to the properties of Thymosin. Please feel free to join our forum.  We hope you enjoy the site.

Shan (Webmaster).